Pelvic floor muscle failure and impaired vaginal microbiocenosis: results of combination treatment

DOI

https://dx.doi.org/10.18565/aig.2019.4.118-124

Dikke G.B.
F.I. Inozemtsev Academy of Medical Education, Saint Petersburg, Russia

Background. Pelvic floor muscle failure (PFMF) that is manifested by perineal incompetence is concurrent with vaginal dysbiosis in 79% of cases and often has a polymicrobial etiology, which requires appropriate treatment.
Case report. The paper describes a clinical case of a female patient diagnosed with PFMF (N81.8). This patient underwent smear microscopy, pH-metry, and evaluation of pelvic floor muscle strength; questionnaires were used. Treatment was performed, which included the combination drug metronidazole/miconazole/lidocaine/viseptol and stimulator-based pelvic floor muscle training.
Treatment for dysbiosis was effective when the above drug was administered; there were no recurrences during the follow-up period. Stimulator-based treatment for PFMF could reduce the frequency and severity of symptoms (from 94.8 to 69.8 PFDI-20 scores; p = 0.03) and dyspareunia (from 80 to 20 visual analogue scale scores; p = 0.03), improve sexual function (from 15.3 to 27.2 FSFI scores; p = 0.001), and prevent progressive PFMF and recurrent dysbiosis.
Conclusion. The described clinical case showed that the combination treatment of perineal incompetence with the use of stimulators during the pregravid preparation period could reduce the incidence and severity of symptoms of stress urinary incontinence and dyspareunia, prevent postpartum progressive PFMF, as well as recurrent vaginal dysbiosis, and improve sexual function.

pelvic floor muscle failure

vaginal dysbiosis

Oxford scale

perineometer

Kegel exercises

vaginal stimulators

metronidazole

miconazole

Full text (in Russian)

Дикке Г.Б., Кочев Д.М. Дисфункция тазового дна до и после родов и превентивные стратегии в акушерской практике. Акушерство и гинекология. 2016; 5: 9-15. https://dx.doi.org/10.18565/aig.2017.5.9-15. [Dikke GB, Kochev DM. Pelvic dysfunction before and after childbirth and preventive strategies in obstetric practice. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2016; 5: 9-15. https://dx.doi.org/10.18565 / aig.2017.5.9-15 (in Russian)].
Memon H.U., Handa V.L. Vaginal childbirth and pelvic floor disorders. Womens Health. 2013; 9(3): 265-77. https://dx.doi.org/10.2217/whe.13.17.
Тотчиев Г.Ф., Токтар Л.Р., Тигиева А.В., Завадина Е.В. Состояние влагалищного биотопа у пациенток репродуктивного возраста, страдающих несостоятельностью тазового дна. Вестник Российского университета дружбы народов. Серия: Медицина. 2013; 5: 146-50. [Totchiev G.F., Toktar L.R., Tigieva A.V., Zavadina E.V. The state of the vaginal biotope in patients of reproductive age suffering from pelvic floor failure. Bulletin of RUDN. Series: Medicine. 2013; 5: 146-50. (in Russian)].
Хрянин А.А., Решетников О.В. Бактериальный вагиноз. Новые представления о микробном биосоциуме и возможности лечения. Медицинский совет. 2014; 17: 128-32. https://dx.doi.org/10.21518/2079-701X-2014-17-128-133. [Khryanin A.A., Reshetnikov O.V. Bacterial vaginosis. New ideas about microbial biosocium and treatment options. Medical advice. 2014; 17: 128-132. DOI: 10.21518 / 2079-701X-2014-17-128-133 (in Russian)].
Bradshaw C.S., Sobel J.D. Current treatment of bacterial vaginosis-limitations and need for innovation. J. Infect. Dis. 2016; 214(Suppl. 1): 14-20. https://dx.doi.org/10.1093/infdis/jiw159.
Дикке Г.Б. Алгоритм ранней диагностики и консервативного лечения дисфункции тазового дна: 5 STEPS. М.; 2018. 24 с. [Dikke G.B. Algorithm of early diagnostic and conservative treatment of pelvic floor dysfunction: 5 STEPS. M., 2019. 24 p. (in Russian)].
Петухов В.С. Вагинальные конусы и реабилитация тазового дна (обзор литературы). Репродуктивное здоровье Восточная Европа. 2016; 6(2): 232-49. [Petukhov V.S. Vaginal cones and pelvic floor rehabilitation (literature review). Reproductive health. Eastern Europe. 2016; 2 (6): 12-29. (in Russian)].
Дикке Г.Б., Кучерявая Ю.Г., Суханов А.А., Кукарская И.И., Щербатых Е.Ю. Современные методы оценки функции и силы мышц тазового дна у женщин. Медицинский алфавит. 2019; 1: 80-5. [Dikke G.B., Kucheryavaya Yu.G., Sukhanov AA, Kukarskaya II, Shcherbatykh E.Yu. Modern methods for assessing the function and strength of the pelvic floor muscles in women. Medical alphabet. 2019; 1: 80-5. (in Russian)].
Российское общество дерматовенерологов и косметологов, Российское общество акушеров-гинекологов. Федеральные клинические рекомендации по ведению больных бактериальным вагинозом. М.; 2015. 15 с. [RODVIK, ROAG. Federal clinical guidelines for the management of patients with bacterial vaginosis. M., 2015. 15 p. (in Russian)].
Российское общество дерматовенерологов и косметологов, Российское общество акушеров-гинекологов. Федеральные клинические рекомендации по ведению больных урогенитальным кандидозом. М.; 2015. 18 с. [RODVIK, ROAG. Federal clinical guidelines for the management of patients with urogenital candidiasis. M., 2015. 18 p. (in Russian)].
Wiegersma M., Panman C.M.C.R., Berger M.Y., De Vet H.C.W., Kollen B.J., Dekkr J.H. Minimal important change in the pelvic floor distressinventory – 20 among women opting for conservative prolapse treatment. Am. J. Obstet. Gynecol. 2017; 216(4): 397. e1-397. e7. https://dx.doi.org/10.1016/j.ajog.2016.10.010.
Rosen R., Brown C., Heiman J., Leiblum S., Meston C., Shabsigh R. et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J. Sex Marital Ther. 2000; 26(2): 191-208. https://dx.doi.org/10.1080/009262300278597.
Дикке Г.Б., Аполихина И.А., Кочев Д.М., Щербатых Е.Ю. Распространенность дисфункции тазового дна среди акушеров-гинекологов и факторы, влияющие на выбор терапевтических подходов. Акушерство и гинекология. 2017; 10: 105-13. https://dx.doi.org/10.18565/aig.2017.10. [Dikke G.B., Apolikhina I.A., Kochev D.M., Shcherbatykh E.Yu. The prevalence of pelvic floor dysfunction among obstetrician-gynecologists and factors influencing the choice of therapeutic approaches. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2017; 10: 105-13. DOI: 10.18565 / aig.2017.10 (in Russian)].
Sherrard1 J., Donders G., White D., Jensen J.S. European (IUSTI/WHO) guideline on the management of vaginal discharge, 2011. 23р. Available at: http://www.iusti.org/
Truter I., Graz M. Bacterial vaginosis: Literature review of treatment options with specific emphasis on non-antibiotic treatment. Review. Afr. J. Pharm. Pharmacol. 2013; 7(48): 3060-7. https://dx.doi.org/10.5897/AJPPX2013.0001.
De Backer E. Antibiotic susceptibility and molecular diagnosis of Atopobium vaginae, a new pathogen in bacterial vaginosis. Ghent, Belgium: Ghent University. Faculty of Medicine and Health Sciences; 2010. 11 р.
Савичева А.М., Шипицина Е.В. Микробиота влагалища при бактериальном вагинозе. Аспекты диагностики и терапии. Медицинский совет. 2014; 9: 90-4. https://dx.doi.org/10.21518/2079-701X-2014-9-90-95. [Savicheva A.M., Shipitsina E.V. Vaginal microbiota with bacterial vaginosis. Aspects of diagnosis and therapy. Medical advice. 2014; 9: 90-4. DOI: 10.21518 / 2079-701X-2014-9-90-95 (in Russian)].
Barasch A., Griffin A.V. Miconazole revisited: new evidence of antifungal efficacy from laboratory and clinical trials. Future Microbiol. 2008; 3(3): 265-9. https://dx.doi.org/10.2217/17460913.3.3.265.
Weese J.S., Walker M., Lowe T. In vitro miconazole susceptibility of meticillin-resistant Staphylococcus pseudintermedius and Staphylococcus aureus. Vet. Dermatol. 2012; 23: 400‐2. https://dx.doi.org/10.1111/j.1365-3164.2012.01068.x.
Nenoff P., Koch D., Krüger C., Drechsel C., Mayser P. New insights on the antibacterial efficacy of miconazole in vitro. Mycoses. 2017; 60(8): 552-7. https://dx.doi.org/ 10.1111/myc.12620.
Панкрушева Т.А., Ерофеева Л.Н., Орлова Т.В., Курилова О.О. Суппозитории. Современный взгляд на лекарственную форму. Монография. Курск: КГМУ; 2017. 212 с. [Suppositories. Modern look at the dosage form. Monograph / team of authors: T.A. Pankrusheva et al. – Kursk: KSMU; 2017. 212 p. (in Russian)].
Минаев Н.Н., Провоторова Т.В. Отдаленные результаты применения препарата нео-пенотран форте для лечения пациенток с бактериальным вагинозом. Молодой ученый. 2015; 6: 283-7. [Minaev N.N., Provotorova T.V. Long-term results of the use of the drug neo-penotran forte for the treatment of patients with bacterial vaginosis. Young scientist. 2015; 6: 283-7.(in Russian)].
Hagen S., Stark D. Conservative management of pelvic organ prolapse in women. Cochrane Database Syst. Rev. 2011; 12: CD003882. https://dx.doi.org/10.1002/14651858.CD003882.pub4.
Braekken I.H., Majida M., Engh M.E. Morphological changes after pelvic floor muscle training measured by 3-dimensional ultrasonography: a randomized controlled trial. Obstet Gynecol. 2010; 115(2, Pt 1): 317-24. https://dx.doi.org/10.1097/AOG.0b013e3181cbd35f.
Losada L., Amundsen C.L., Ashton-Miller J., Chai T., Close C., Damaser M. et al. Expert panel recommendations on lower urinary tract health of women across their life Span. J. Womens Health (Larchmt). 2016; 25(11): 1086-96. https://dx.doi.org/10.1089/jwh.2016.5895.
Серов В.Н., Аполихина И.А., Кубицкая Ю.В., Железнякова А.И. Электростимуляция мышц тазового дна в лечении недержания мочи у женщин. Акушерство и гинекология. 2011; 7-2: 51-5. [Serov V.N., Apolikhina I.A., Kubitskaya Yu.V., Zheleznyakova A.I. Electrical stimulation of the pelvic floor muscles in the treatment of urinary incontinence in women. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2011; 7 (2): 51-5. (in Russian)].
Dumoulin C., Hay-Smith J., Habee-Seguin G.M., Mercier J. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women: A short version Cochrane systematic review with meta-analysis. Neurourol. Urodyn. 2015; 34(4): 300-8. https://dx.doi.org/10.1002/nau.22700.
Lipp A., Shaw C., Glavind K. Mechanical devices for urinary incontinence in women. Cochrane Database Syst. Rev. 2014; (12): CD001756. https://dx.doi.org/10.1002/14651858.CD001756.pub6.

Received 27.03.2019

Accepted 19.04.2019

Dikke, Galina B., MD, associate professor, professor of the Department of Obstetrics and Gynecology with a course of reproductive medicine. F.I. Inozemtsev Academy
of Medical Education. 190013, St. Petersburg, Moscow Ave, 22, letter M. Tel.: +78123347650. E-mail: galadikke@yandex.ru. ORCID.org 0000-0001-9524-8962.

For citation: Dikke G.B. Pelvic floor muscle failure and impaired vaginal microbiocenosis: results of combination treatment. Akusherstvo i Ginekologiya/Obstetrics and Gynecology.2019; (4): 118-24. (in Russian)
https://dx.doi.org/10.18565/aig.2019.4.118-124

Pelvic floor muscle failure and impaired vaginal microbiocenosis: results of combination treatment

Dikke G.B.

Keywords

References

About the Authors

Similar Articles